Applying Bioinformatic Tools for Modeling and Modifying Type II <i>E. coli</i> l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia

Journal Title: International Journal of Cancer Management - Year 2017, Vol 10, Issue 3

Abstract

Background Asparginase is known to be one of the most important bedrocks of acute lymphoblastic leukemia (ALL) treatment in almost all pediatric regimens in treatment protocols. <i>Escherichia coli</i> L-Asparginase (EC 3.5.1.1) is one of the most common resources to produce this enzyme. One of the affordable methods to overcome the side effects of drug is utilizing bioinformatic tools in the form of In silico study. In this study we designed a new structure of L-Asparginase to decrease its toxicity, reduce some side effects and increase the stability. Methods We used some bioinformatics software and servers like Toxin red, Popmusic, kobami and I-TASSER server to reduce toxicity level of enzyme, and to increase stability and enzyme half-life. Results We obtained 6 protein sequences in which the best was Mut 6 with four changes in structure: L23G, K129L, S263C and R291F. In contrast to the wild type, the new predicted protein is not toxic and has 25 hours more half-life and 600 kcal/mol more stable with no significant change in protein secondary, tertiary structure, antigenicity and allergenicity. Conclusions Finally, sequence number 6 was the only sequence with all distinct characteristics: non-toxic, more stability and more half life.

Authors and Affiliations

Mahdieh Mahboobi, Hamid Sedighian, Mojtaba Hedayati CH, Bijan Bambai, Saeed Esmaeil Soofian, Jafar Amani

Keywords

Related Articles

Evaluation of Anti-Melanogenic and Cytotoxic Activities of <i>Phlomis caucasica</i> on Human Melanoma SKMEL-3 Cells

Background Under normal physiological condition, melanosomal melanin acts as a natural UV photoprotective filter. However, after long exposure to UV radiation, melanin has shown t...

Association Between Cytochrome 1B1*3 Polymorphism and the Breast Cancer in a Group of IranianWomen

Background: As a hormone-dependent cancer, estrogen is involved in the development of breast cancer. CYP1B1 belongs to the P450 superfamily of enzymes and is involved in the metabolism of estrogen. The present study inve...

Supraclavicular Metastasis from Infraclavicular Organs: Retrospective Analysis of 18 Patients

Background Supraclavicular fossa masses have usually been malignant lesions. When fine needle aspiration biopsy results have not been satisfactory excisional biopsy of supraclavic...

Production of Specific Anti-EGFR Single Chain Antibodies: A Promising Strategy in the Immunotherapy of EGFR Expressing Tumor Tissues

Background: EGFR (Epidermal growth factor receptor) is overexpressed in a number of cancers and plays an important role in several phenomena such as aggressiveness of tumor, decreased survival of the patient, and resista...

Investigation of Stigma Phenomenon in Cancer: A Grounded Theory Study

Background Adjustment to cancer as a stressful event is affected by bio-psycho-social factors. Objectives This study aimed to investigate stigma phenomenon, the process of formati...

Download PDF file
  • EP ID EP237328
  • DOI 10.5812/ijcm.5785
  • Views 70
  • Downloads 0

How To Cite

Mahdieh Mahboobi, Hamid Sedighian, Mojtaba Hedayati CH, Bijan Bambai, Saeed Esmaeil Soofian, Jafar Amani (2017). Applying Bioinformatic Tools for Modeling and Modifying Type II <i>E. coli</i> l-Asparginase to Present a Better Therapeutic Agent/Drug for Acute Lymphoblastic Leukemia. International Journal of Cancer Management, 10(3), -. https://europub.co.uk./articles/-A-237328